Last reviewed · How we verify
NCT06158204
Improving Metabolic & Mental Health in Female Healthcare Shift Workers
NA trial testing Lifestyle Intervention in Sleep, Inadequate in 13 participants. Participants enrolled and being followed up; not accepting new ones.
19 June 2024
Quick facts
| Lead sponsor | Auburn University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 13 |
| Start date | 2 January 2024 |
| Primary completion | 19 June 2024 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lifestyle Intervention
Conditions studied
- Sleep, Inadequate — all drugs for Sleep, Inadequate →
- Overweight and Obesity — all drugs for Overweight and Obesity →
- Work Related Stress — all drugs for Work Related Stress →
- Healthy Lifestyle — all drugs for Healthy Lifestyle →
Sponsor
Auburn University
Who can join
Adults 18 to 50, female only, with Sleep, Inadequate or Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Circadian rhythm disruption caused by shift work alters metabolic and hormonal pathways, which accelerates chronic disease onset, leading to decreased quality and quantity of life. Preclinical studies indicate that optimizing nutrient and sleep/rest timing can mitigate these effects. Female nightshift healthcare workers will be recruited to participate in a randomized crossover trial in which participants will be expected to follow the prescribed lifestyle intervention for eight weeks during the first or second eight-week periods of the study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Randomized Controlled Crossover Lifestyle Intervention to Improve Metabolic and Mental Health in Female Healthcare Night-Shift Workers.
Robinson LA, Lennon S, Pegel AR, Strickland KP, et al · · 2025 · PMID 41228416 · DOI 10.3390/nu17213342
Verify or expand the search:
- PubMed search for NCT06158204
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lifestyle Intervention
Trials testing the same drug.
- NCT07310407 — Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) · Phase 2 · not yet recruiting
- NCT07341841 — Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study · NA · enrolling by invitation
- NCT07085923 — Norwegian Mental Illness Heart Health Study · NA · recruiting
- NCT06741865 — The INSPIRE Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement · NA · recruiting
- NCT06054035 — SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabet · Phase 4 · recruiting
Other recruiting trials for Sleep, Inadequate
Currently open trials in the same condition.
- NCT05420766 — Impact of Sleep Duration on Immune Balance in Urban Children With Asthma · NA · recruiting
Other Auburn University trials
Trials by the same sponsor.
- NCT05621538 — A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder · NA · recruiting
- NCT06274112 — Using TMS to Understand Neural Processes of Social Motivation · NA · recruiting
- NCT07489105 — Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function · NA · recruiting
- NCT06565637 — Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders · Phase 1 · recruiting
- NCT06531863 — Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06158204 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 29 May 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Auburn University
- Last refreshed: 8 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06158204.